Elevance Health Inc (ELV) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.

Total Revenue Chart for Elevance Health Inc

Elevance Health Inc (ELV) revenue for FY2025 was USD 199.1B, a 12.6% change from FY2024. Elevance Health Inc's revenue grew from USD 11.1B in 1998 to USD 199.1B in 2025 (1698.4% over 27 years). Earnings per share grew from USD 1.10 in 2000 to USD 25.53 in 2025 (2228.8%). Revenue compound annual growth rate: 5-year CAGR of 10.3%, 10-year CAGR of 9.7%, 20-year CAGR of 7.7%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$84.88B
Implied Share Price
$391.40
Enterprise Value
$102.79B
Revenue (TTM)
$201.11B
EBITDA
$8.32B
Profit Margin
2.47%
Trailing P/E
17.30
Forward P/E
14.04
Price/Book (MRQ)
1.83
Price/Sales (TTM)
0.42
EV/EBITDA
0.00
EV/Revenue
0.51
Dividend Yield
1.75%
Book Value
$206.99
Free Cash Flow (FY2025)
$3.17B
Free Cash Flow Yield
3.74%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.